Validation of a 384 gene hybridization capture-based pharmacogenomics NGS panel: sensitivity, specificity, accuracy, and reproducibility in calling star alleles for drug metabolism genes

Frontage has developed a next-generation sequencing (NGS)-based method to rapidly determine the genotype of 300+ genes involved in ADME, called the Frontage PGx NGS Test.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Phone

This field is for validation purposes and should be left unchanged.

Validation of a 384 gene hybridization capture-based pharmacogenomics NGS panel: sensitivity, specificity, accuracy, and reproducibility in calling star alleles for drug metabolism genes

Resources to Consider

WebninarAnalytical Challenges for CMC Development of Cell and Gene...

General Practices for Critical Reagents Usage in Bioanalytical Labs

Meeting public health and regulatory demands for next generation...

The role of genetic toxicology in drug development

Gene & Cell Therapy Analytical Services

Biologics, Gene and Cell Therapy Services

GeneTox: A Pivotal Part of Safety Assessment

GMP Analytical Testing in Gene Therapy Products

The Next Generation Central Lab

Genetic Toxicology

Gene Therapy Virus Packaging & Quality Control

Bioanalytical Developments in Cell and Gene Therapies